Allergan Inc. (NYSE:AGN): Following a meeting with Allergan’s CEO, RBC Capital reports that the company still expects solid growth from its aesthetics and specialty pharmaceuticals businesses. The firm views the shares as undervalued while macroeconomic related concerns remain unwarranted.
Investing Insights: Is Home Depot a BUY?
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) has been added to U.S. 1 List at Bank of America Merrill Lynch.
Urban Outfitters Inc. (NASDAQ:URBN) reported higher than expected EPS for Q2, causing RBC Capital to think that the company is poised to perform well in the Fall. The firm keeps an Outperform rating.
Cree Inc. (NASDAQ:CREE) is seen by Cantor as a favorite name in the group because it is a participant in strong secular growth markets, its financial performance is becoming better, and continues to gain market share. The firm reiterates its Buy rating and $46 price target.
News Corp. (NASDAQ:NWSA) predicted that its EBIT would grow in the high-single to low-double digit range during FY13, Citigroup predicts that the company’s EBIT will increase just over 11 percent, which excludes the impact of the Fox Sports Australia consolidation. The firm keeps believing that the stock has a worth of about $26 per share, and it keeps a Buy rating.
Don’t Miss: Apple’s iPhone is TROUNCING Microsoft.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.